Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $9.8M | $17M | $25M | $20M | |
Revenue Growth (YoY) | -- | -- | 74.12% | 46.99% | -19.84% | |
Cost of Revenues | -- | $9.5M | $17M | $27.1M | $24.6M | |
Gross Profit | -- | $244.8K | $43.9K | -$2.1M | -$4.6M | |
Gross Profit Margin | -- | 2.51% | 0.26% | -8.42% | -22.83% | |
R&D Expenses | -- | $541.2K | $1M | $1.9M | $2M | |
Selling, General & Admin | -- | $3.1M | $6.6M | $10M | $20.9M | |
Other Inc / (Exp) | -- | -$424.4K | -$4.1M | $2.2M | $1.6M | |
Operating Expenses | -- | $4.2M | $9.1M | $12.6M | $24.9M | |
Operating Income | -- | -$3.9M | -$9M | -$14.7M | -$29.5M | |
Net Interest Expenses | -- | $265.4K | $446.1K | $1.7M | $5.9M | |
EBT. Incl. Unusual Items | -- | -$4.6M | -$13.6M | -$14.2M | -$33.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $887.7K | -- | -- | |
Net Income to Company | -- | -$6M | -$14.5M | -$14.2M | -$33.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$4.6M | -$14.5M | -$14.2M | -$33.8M | |
Basic EPS (Cont. Ops) | -- | -$0.10 | -$0.30 | -$0.29 | -$0.67 | |
Diluted EPS (Cont. Ops) | -- | -$0.10 | -$0.30 | -$0.29 | -$0.67 | |
Weighted Average Basic Share | -- | $48.6M | $48.6M | $48.6M | $50.6M | |
Weighted Average Diluted Share | -- | $48.6M | $48.6M | $48.6M | $50.6M | |
EBITDA | -- | $1M | -$7.5M | -$3.3M | -$17M | |
EBIT | -- | -$4.4M | -$13M | -$12.4M | -$27.1M | |
Revenue (Reported) | -- | $9.8M | $17M | $25M | $20M | |
Operating Income (Reported) | -- | -$3.9M | -$9M | -$14.7M | -$29.5M | |
Operating Income (Adjusted) | -- | -$4.4M | -$13M | -$12.4M | -$27.1M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $3.4M | $15.5M | $10.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $4.3M | $14.1M | $13M | |
Gross Profit | -- | -- | -$861.4K | $1.4M | -$2.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $415.2K | $377.9K | $1.4M | |
Selling, General & Admin | -- | -- | $1.9M | $1.1M | $17.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | $3.1M | $2M | $20.5M | |
Operating Income | -- | -- | -$4M | -$602.9K | -$23.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -$7.6M | -$2.2M | -$27.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $887.7K | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$8.5M | -$2.2M | -$27.2M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.18 | -$0.05 | -$0.48 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.18 | -$0.05 | -$0.48 | |
Weighted Average Basic Share | -- | -- | $48.6M | $48.6M | $57M | |
Weighted Average Diluted Share | -- | -- | $48.6M | $48.6M | $57M | |
EBITDA | -- | -- | -$7.8M | $3.4M | -$16.1M | |
EBIT | -- | -- | -$8M | -$977.1K | -$21.3M | |
Revenue (Reported) | -- | -- | $3.4M | $15.5M | $10.3M | |
Operating Income (Reported) | -- | -- | -$4M | -$602.9K | -$23.1M | |
Operating Income (Adjusted) | -- | -- | -$8M | -$977.1K | -$21.3M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $17.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $22.9M | |
Gross Profit | -- | -- | -- | -- | -$5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | $2.1M | |
Selling, General & Admin | -- | -- | -- | -- | $23.8M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | $27.3M | |
Operating Income | -- | -- | -- | -- | -$32.3M | |
Net Interest Expenses | -- | -- | -- | -- | $2.9M | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$35.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -$35.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$35.2M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.65 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.65 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -$20M | |
EBIT | -- | -- | -- | -- | -$29M | |
Revenue (Reported) | -- | -- | -- | -- | $17.9M | |
Operating Income (Reported) | -- | -- | -- | -- | -$32.3M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$29M |
Period Ending | 2021-01-04 | 2022-01-04 | 2023-01-04 | 2024-01-04 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $3.5M | $13.2M | $10.5M | $19.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $28.9K | $55.3K | $286.6K | $163.5K | |
Inventory | -- | $75.9K | $866.7K | $3M | $2.3M | |
Prepaid Expenses | -- | $635.2K | $741.7K | $682.5K | $1.2M | |
Other Current Assets | -- | $4.8K | $11.4K | $135.3K | $150.2K | |
Total Current Assets | -- | $5.6M | $18M | $20.5M | $25.7M | |
Property Plant And Equipment | -- | $8M | $21M | $20.3M | $14.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | $19.9K | $33.3K | $159.6K | $183.9K | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $13.6M | $39M | $40.9M | $40.2M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | $147.2K | $102.6K | $637.9K | $609.5K | |
Current Portion Of Long-Term Debt | -- | $8.6M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $443.7K | $650.7K | $2.2M | $412.6K | |
Other Current Liabilities | -- | -- | $5.6M | $7.3M | $10.4M | |
Total Current Liabilities | -- | $10.5M | $10.4M | $15.9M | $17.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $11M | $18.5M | $33.3M | $72.9M | |
Common Stock | -- | $12.7M | $51.3M | $4.4K | $5.7K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -$10M | -$30.8M | $7.6M | -$32.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $2.7M | $20.5M | $7.6M | -$32.7M | |
Total Liabilities and Equity | -- | $13.6M | $39M | $40.9M | $40.2M | |
Cash and Short Terms | -- | $3.5M | $13.2M | $10.5M | $19.4M | |
Total Debt | -- | $8.6M | -- | -- | -- |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $297.2K | |
Inventory | -- | -- | -- | -- | $2.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | $652.6K | |
Total Current Assets | -- | -- | -- | -- | $14.2M | |
Property Plant And Equipment | -- | -- | -- | -- | $10.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | $25M | |
Accounts Payable | -- | -- | -- | -- | $2.1M | |
Accrued Expenses | -- | -- | -- | -- | $2.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $274.1K | |
Other Current Liabilities | -- | -- | -- | -- | $9M | |
Total Current Liabilities | -- | -- | -- | -- | $15.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $76.2M | |
Common Stock | -- | -- | -- | -- | $5.9K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | -$51.2M | |
Total Liabilities and Equity | -- | -- | -- | -- | $25M | |
Cash and Short Terms | -- | -- | -- | -- | $9M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$6M | -$14.5M | -$14.2M | -$33.8M | |
Depreciation & Amoritzation | -- | $5.4M | $5.5M | $9.1M | $10M | |
Stock-Based Compensation | -- | $643.7K | $868.8K | $1.7M | $2M | |
Change in Accounts Receivable | -- | -$179K | -$191.6K | -$210K | $186.8K | |
Change in Inventories | -- | -$844.6K | -$1.7M | -$2.1M | $657.6K | |
Cash From Operations | -- | $2.1M | -$4M | -$5.5M | -$14.9M | |
Capital Expenditures | -- | $17.7M | $22.9M | $8.2M | $4.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$17.7M | -$22.9M | -$8.2M | -$4.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $5.1M | $14.9M | $15.5M | $7.5M | |
Long-Term Debt Repaid | -- | -$2.4M | -$1.5M | -$4.2M | -$7.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | $29.6M | |
Cash From Financing | -- | $32.4M | $43.1M | $11.3M | $28.6M | |
Beginning Cash (CF) | -- | $3.5M | $3.5M | $13.2M | $10.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $16.8M | $16.2M | -$2.4M | $8.9M | |
Ending Cash (CF) | -- | $15M | $13.2M | $10.5M | $19.4M | |
Levered Free Cash Flow | -- | -$15.6M | -$26.9M | -$13.7M | -$19.7M |
Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$6M | -$12M | -$6.6M | |
Depreciation & Amoritzation | -- | -- | $5.4M | $4.7M | $4.8M | |
Stock-Based Compensation | -- | -- | $643.7K | $582K | $785K | |
Change in Accounts Receivable | -- | -- | -$179K | -$177K | -$292K | |
Change in Inventories | -- | -- | -$844.6K | -$308K | -$961K | |
Cash From Operations | -- | -- | $2.1M | -$6.1M | -$1.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$17.7M | -$4M | -$4.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $5.1M | $7.5M | -- | |
Long-Term Debt Repaid | -- | -- | -$2.4M | -$3.9M | -$3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | $32.4M | $3.6M | -$3M | |
Beginning Cash (CF) | -- | -- | $3.5M | $10.5M | $13.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -$5.4M | -- | -$337K | |
Additions / Reductions | -- | -- | $16.8M | -$6.5M | -$9.6M | |
Ending Cash (CF) | -- | -- | $15M | $4M | $3.3M | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -$35.2M | |
Depreciation & Amoritzation | -- | -- | -- | -- | $9M | |
Stock-Based Compensation | -- | -- | -- | $581.7K | $3.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -$286.3K | |
Change in Inventories | -- | -- | -- | -- | -$77.1K | |
Cash From Operations | -- | -- | -- | -- | -$16.6M | |
Capital Expenditures | -- | -- | -- | $4M | $4.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$4.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $15M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$6.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | $4.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -$17M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -$21.3M |
Period Ending | 2021-01-04 | 2022-01-04 | 2023-01-04 | 2024-01-04 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.